Hydrazine

Hydrazine

SCHEMBL3878173

NN.c1cc2ccc1o2

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyne SCHEMBL10357623 0.82
SCHEMBL687192 0.78
SCHEMBL15619251 0.78
SCHEMBL22251585 0.75 ALDH1A1 (0.38)
SCHEMBL9344184 0.72
SCHEMBL9521720 0.71
Isopropyl Alcohol SCHEMBL20590526 0.70 ALDH1A1 (0.40)
Acetic Acid SCHEMBL11212519 0.68 FFAR3 (0.44)
Propanol SCHEMBL20590519 0.66 ALDH1A1 (0.33)
SCHEMBL2889732 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827444-B1 MNK1 OR MNK2 INHIBITORS BOEHRINGER INGELHEIM INT (DE) 2013-05-15 EP disclosed
US-20090163520-A1 MNK1 or MNK2 Inhibitors DEVELOGEN AKTIENGESELLSCHAFT (DE) 2009-06-25 US disclosed
US-20080280941-A1 8-Phenoxy-Gamma Carboline Derivatives PHARMA C S.A. (FR) 2008-11-13 US disclosed
EP-1827444-A2 MNK1 OR MNK2 INHIBITORS DeveloGen Aktiengesellschaft (DE) 2007-09-05 EP disclosed
EP-1756102-A1 8-PHENOXY-GammaCARBOLINE DERIVATIVES Pharma C S.A. (FR) 2007-02-28 EP disclosed
WO-2007009485-A1 SUBSTITUTED 8-PHENOXY-Y-CARBOLINE DERIVATIVES WITH 5HT1 ACTIVITY PHARMA C S.A. (FR) 2007-01-25 WO disclosed
EP-1746099-A1 Mnk1 or Mnk2 inhibitors DeveloGen Aktiengesellschaft (DE) 2007-01-24 EP disclosed
WO-2006066937-A2 MNK1 OR MNK2 INHIBITORS DEVELOGEN AKTIENGESELLSCHAFT (DE) 2006-06-29 WO disclosed
WO-2005095396-A1 8-PHENOXY-Ϝ CARBOLINE DERIVATIVES PHARMA C S.A. (FR) 2005-10-13 WO disclosed